MoCRA for U.S. Cosmetics Export
AllCosmetics ExportCosmetics Export Certification and Regulatory ApprovalMoCRA for U.S. Cosmetics ExportCPNP for Cosmetics Export to EuropeCDSCO for Cosmetics Export to IndiaCosmetic Quality ControlClinical Trial/TestingDocumentation and Preparation ProceduresCERTICOS Features and Use CasesMarket Entry StrategyOther Questions
The MoCRA (Modernization of Cosmetics Regulation Act), enacted in the United States in 2022, significantly expands the FDA's authority over cosmetics to enhance product safety, transparency, and consumer trust.
1. Key Roles of MoCRA
- Mandatory registration of cosmetic manufacturing facilities and product listings.
- Mandatory reporting of serious adverse events.
- Enforcement of stricter quality control through GMP (Good Manufacturing Practices) compliance.
- Tightened regulations on specific ingredients, such as fragrance allergens.
- Requirement to designate a U.S. Responsible Person to manage consumer complaints and compliance.
2. MoCRA Compliance Process
- Facility Registration: Both domestic U.S. manufacturers and foreign cosmetic exporters must register their manufacturing facilities with the FDA.
- Product Listing: All cosmetic products must be listed with the FDA, and existing products must complete this registration within designated deadlines.
- Safety Substantiation & Ingredient Review: Companies must verify that their products comply with MoCRA standards and maintain robust safety substantiation data.
- Labeling Compliance: Product labels must be updated to satisfy new FDA requirements, including professional use labeling and allergen disclosures.
- Adverse Event Reporting & Recalls: Establish tracking systems to report serious adverse events to the FDA and maintain a clear framework for product recalls.
3. Important Considerations for MoCRA
- Companies must meet significantly enhanced requirements compared to older FDA cosmetic regulations.
- Failure to complete facility and product registrations within the legal deadlines can result in market enforcement or suspension of U.S. sales.
- Formulations containing specific targeted ingredients will require additional testing and regulatory scrutiny.
4. Leveraging the CDRI Solution
- CDRI's AI-powered regulatory platform ensures a fast, accurate MoCRA registration process.
- It provides comprehensive services, including FDA requirement screening, safety data compilation, and automated updates reflecting the latest regulatory shifts.
The documents required for MoCRA compliance for U.S. cosmetics certification must be prepared to meet the FDA’s updated cosmetics regulatory requirements.
1. Manufacturer and Facility Registration Documents - Manufacturer name and address - Facility registration information, including U.S. or overseas manufacturing facilities - Overview of the manufacturing process and confirmation of GMP, or Good Manufacturing Practices, compliance
2. Product Listing Documents - Product name and category - Brand name and distributor information - Product formula, including full ingredient list, or INCI List - Product intended use and application area
3. Product Safety Assessment Reports - Skin safety test results, including irritation, corrosion, and allergic reaction assessments - Toxicity and microbiological test results - Preservative efficacy and stability assessment reports - Test reports for heavy metals and harmful substances
4. Labeling and Packaging Documents - Product label design, with English labeling required - Ingredient declaration and expiration date labeling - Warning statements and directions for use in compliance with existing U.S. FDA cosmetics requirements
5. Adverse Event Reporting and Claim Management Materials - Materials showing the establishment of an adverse event reporting system for potential product-related adverse reactions - Recall procedures and consumer response plans - Adverse event data for existing products, if applicable
6. Other Required Documents - Documents designating the U.S. responsible distributor or responsible party, required for products distributed in the United States - Batch-specific quality control documents - Risk management plan under MoCRA requirements
7. Use of CDRI Solutions CDRI provides AI-based cosmetics export and overseas regulatory approval solutions to automatically analyze the essential documents required for MoCRA compliance and support fast and accurate FDA registration procedures. By reflecting MoCRA regulatory updates in real time, CDRI helps minimize errors that may occur during the certification process.
The time required for MoCRA compliance may vary depending on U.S. cosmetics export, cosmetics certification, and regulatory approval procedures, as well as product type, manufacturing facility registration status, and the completeness of submitted documents. In general, the following timelines may be expected.
1. Manufacturer and Facility Registration - Registration of U.S. or overseas manufacturing facilities may take approximately 2 to 4 weeks. - Applications are submitted through the FDA registration system, and all required information must be entered accurately. - Registration can proceed more quickly if cosmetics export documents, such as manufacturer information and quality control documents, are prepared in advance.
2. Product Listing and Ingredient Review - Product listing and ingredient review may take an average of 1 to 3 months. - The ingredient list, safety assessment materials, and product formula must meet FDA requirements. Errors or additional requests may cause delays. - Cosmetic ingredient requirements must be followed, and products containing certain ingredients may require additional review.
3. Product Safety Assessment and Testing - Testing such as skin safety testing, microbiological testing, and heavy metal analysis may take 2 to 6 months. - Before exporting cosmetics to the United States, a safety assessment report under MoCRA requirements is required. If existing test results are not accepted, additional testing may be required. - To meet overseas cosmetics certification requirements, companies must obtain reports from accredited testing institutions.
4. Labeling and Document Review - Reviewing whether the product label complies with FDA requirements may take approximately 2 to 4 weeks. - Information such as ingredient declaration, warning statements, and directions for use must be accurate. If information is incomplete, supplementary requests may occur. - Labeling must comply with applicable U.S. FDA regulations and relevant regulatory requirements, and errors may delay registration.
5. Final Approval and Registration Completion - After all procedures are completed, the FDA’s final review may take an additional 2 to 4 weeks. - Even after registration, companies must continue adverse event reporting and reflect regulatory updates in accordance with MoCRA. - Additional testing and updated document submissions may be required when renewing cosmetics export certification.
6. Use of CDRI Solutions - CDRI supports faster and more efficient MoCRA compliance procedures through AI-based U.S. cosmetics export and overseas regulatory approval solutions. - By providing product ingredient review, automated document analysis, and updates reflecting the latest FDA requirements, CDRI helps minimize unnecessary delays.
The cost of MoCRA compliance may vary depending on the U.S. cosmetics certification process, product type, manufacturing facility registration status, and required testing items. In general, the following costs may be expected.
1. Manufacturer and Facility Registration Costs - Registration fees for U.S. or overseas manufacturing facilities may range from approximately USD 500 to 2,000 per year, or about KRW 650,000 to 2.6 million. - Regular renewal and maintenance costs may also apply after registration.
2. Product Listing and Ingredient Review Costs - Product listing costs may range from approximately USD 200 to 1,000 per product, or about KRW 260,000 to 1.3 million. - Additional costs may apply for reviewing cosmetic ingredient requirements and ingredient certification.
3. Product Safety Assessment and Testing Costs - Testing costs for skin irritation, toxicity testing, microbiological testing, and similar items may average USD 1,000 to 5,000, or about KRW 1.4 million to 7 million. - If certain ingredients are included, additional testing may be required, which may increase costs. - Products must meet FDA safety assessment standards and other applicable regulatory requirements for U.S. cosmetics certification.
4. Labeling and Document Review Costs - Product label review and FDA regulatory compliance review may cost approximately USD 120 to 2,000, or about KRW 150,000 to 2.6 million. - Additional correction costs may arise if errors occur during the cosmetics export document preparation process.
5. Final Approval and Maintenance Costs - Product listing and manufacturing facility maintenance costs may range from approximately USD 1,000 to 5,000 per year, or about KRW 1.3 million to 6.5 million. - Additional testing and regular renewal costs may be incurred under MoCRA requirements.
6. Use of CDRI Solutions - CDRI supports more efficient analysis of MoCRA compliance costs and helps reduce unnecessary expenses through AI-based U.S. cosmetics certification solutions. - Through automated document review and updates reflecting the latest regulations, CDRI helps maximize cost savings.
Product testing during the MoCRA compliance process includes various safety assessments to comply with U.S. FDA requirements and is an essential part of cosmetics export and regulatory approval procedures.
1. Ingredient and Raw Material Safety Assessment - Review the product’s full ingredient list, or INCI List, to confirm that it does not contain ingredients prohibited or restricted under U.S. FDA cosmetics requirements. - Evaluate the toxicity, stability, and allergenic potential of each ingredient according to cosmetic ingredient requirements.
2. Skin and Eye Safety Testing - Skin irritation and corrosion testing: Evaluates the effect of the product on the skin using human application testing or alternative test methods. - Eye irritation and inhalation toxicity testing: Verifies safety for the eyes and respiratory system. For spray-type products, inhalation toxicity should also be assessed.
3. Microbiological and Preservative Efficacy Testing - Microbiological testing: Checks whether the product is contaminated with bacteria, mold, yeast, or other microorganisms. - Preservative efficacy testing: Verifies the effectiveness of preservatives in preventing microbial growth during long-term storage and use.
4. Heavy Metal and Harmful Substance Analysis - Tests whether the levels of heavy metals such as lead, mercury, arsenic, and cadmium exceed permitted standards for FDA cosmetics requirements. - Confirms that allergens and harmful chemical substances are not included.
5. Stability and Shelf-Life Assessment - Conducts product stability testing under environmental factors such as temperature changes, light, and humidity. - Evaluates whether product quality is maintained after long-term storage to determine shelf life.
6. Review of Additional Country-Specific Requirements - In addition to FDA requirements, certain U.S. state regulations or requirements such as halal certification may apply. - Depending on the product type, separate testing may be required if other regulatory certifications are needed.
7. Use of CDRI Solutions - CDRI provides AI-based cosmetics export and overseas regulatory approval solutions to help prevent errors during product testing and support a faster cosmetics certification process. - By reflecting the latest FDA cosmetics testing standards, CDRI automatically analyzes required testing items and helps companies efficiently prepare the necessary test reports.
Common errors during the MoCRA compliance process and their solutions include the following.
1. Manufacturer and Facility Registration Errors - Error: Registration delays caused by inaccurate manufacturing facility information - Solution: Before facility registration, companies should check U.S. FDA requirements and prepare the necessary cosmetics export documents in advance, such as business registration certificates, factory registration certificates, and GMP certificates.
2. Missing Product Ingredient and Raw Material Information -Error: The product contains ingredients that do not meet cosmetic ingredient requirements, or ingredient information is incomplete. - Solution: Companies should review ingredients permitted by the FDA and thoroughly prepare the product’s full ingredient list, or INCI List, and ingredient safety assessment materials.
3. Insufficient Product Safety Assessment Materials - Error: Approval delays caused by insufficient safety test reports, such as skin irritation, toxicity testing, and microbiological testing. - Solution: Required product testing should be completed in advance according to MoCRA requirements, and reports issued by accredited testing institutions should be submitted.
4. Non-Compliance with Labeling and Packaging Regulations - Error: Product label ingredient declarations, warning statements, directions for use, or other information do not comply with FDA requirements. - Solution: Companies should review FDA cosmetics labeling guidelines and confirm that product packaging complies with MoCRA requirements before submission.
5. Product Listing Delays and Incomplete Documents - Error: Product listing rejection due to missing required registration documents or inconsistent data. - Solution: Before product listing, all cosmetics export certification documents, such as product descriptions, safety assessments, ingredient lists, and test reports, should be thoroughly reviewed and prepared according to the latest FDA cosmetics requirements.
6. Omission of Adverse Event Reporting - Error: Under MoCRA, adverse events reported by consumers must be submitted, and failure to do so may lead to legal issues. - Solution: Even after product launch, companies should establish an adverse event monitoring system and report regularly through the FDA reporting system.
7. Use of CDRI Solutions - CDRI provides AI-based cosmetics export and overseas regulatory approval solutions to detect potential errors during MoCRA cosmetics certification in advance and resolve them quickly through an automated review system. - By reflecting the latest FDA cosmetics requirements, providing automated document review, and supporting product testing, CDRI helps companies proceed with certification procedures quickly and accurately.
MoCRA renewal is essential to maintain cosmetics certification and export procedures and must follow the timelines and procedures specified under U.S. FDA requirements.
1. Renewal Cycle - Manufacturer and facility registration: Annual renewal is required. - Product listing: Existing listed products must be renewed every two years, even if there are no changes. - Product safety assessment and ingredient review: Updates are required immediately if there are major ingredient changes. - Adverse event and consumer claim reporting: Reports must be submitted to the FDA as they occur, and continuous updates are required.
2. Renewal Procedure - Review existing registration records: Check registered manufacturer, facility, and product information and submit renewal if any changes have occurred. - Update product ingredients and safety assessment: If ingredients have changed, re-submit the required information to the FDA according to cosmetic ingredient requirements. - Submit test reports: Submit updated skin safety, microbiological testing, heavy metal analysis, and related materials to confirm compliance with MoCRA requirements. - Review labeling and packaging compliance: Update cosmetics export documents according to the latest regulations and review labeling in line with FDA requirements. - Submit final renewal application and wait for approval: After all information has been updated, submit the renewal application to the FDA and wait for final approval.
3. Key Points to Consider During Renewal - Regularly check FDA regulatory updates and prepare in advance to avoid unnecessary delays. - Even for products that have completed cosmetics export certification, immediate re-submission may be required if ingredients or manufacturing processes change. - To ensure consumer safety, companies must operate an adverse event reporting system and continuously manage compliance with FDA requirements.
4. Use of CDRI Solutions - CDRI automatically manages MoCRA renewal procedures through AI-based cosmetics export and overseas regulatory approval solutions and updates country-specific renewal cycles and requirements in real time to support faster certification maintenance. - CDRI helps ensure smooth certification procedures by efficiently handling product changes, updated regulatory requirements, test report review, and related processes.
Organizations that can assist with the MoCRA compliance process include the following.
1. CDRI - CDRI provides AI-based solutions for overseas regulatory approval and quality management to support MoCRA compliance and U.S. cosmetics export quickly and accurately. - CDRI automates manufacturing facility and product listing, ingredient review, safety assessment material preparation, and updates reflecting the latest FDA requirements, enabling companies to manage the certification process efficiently.
2. FDA Cosmetics Certification Service Providers - These providers offer services such as facility registration, product listing, safety data collection and management, full ingredient and label review, and other services under MoCRA.
3. Global Standard Certification Organizations - These organizations support global business activities by providing up-to-date information and expertise through U.S. Agent services for FDA-related procedures.
4. Korea Testing & Research Institute (KTR) - KTR provides services for appointing a U.S. Agent and listing manufacturing facilities and product information with the FDA.
5. ICMC Overseas Certification Management Center - ICMC provides technical support for MoCRA compliance, manufacturing facility registration, product listing, U.S. agent appointment before U.S. cosmetics export, and renewal procedures.
6. Cosmereg - Cosmereg provides MoCRA compliance support services, including FDA facility registration, U.S. Agent services, and product listing management.
CDRI reflects the latest country-specific regulations through AI-based analysis and automates the MoCRA cosmetics certification process to help reduce costs and time. Companies can use CDRI solutions to proceed with U.S. cosmetics export more efficiently and accurately.
Even after completing MoCRA compliance procedures, the following items must be continuously managed to maintain ongoing regulatory compliance.
1. Manufacturer and Facility Registration Renewal - Manufacturer and facility information registered with the FDA must be renewed annually, and any facility changes or business discontinuation must be updated immediately. - Companies should regularly check whether facility maintenance standards comply with MoCRA requirements.
2. Product Listing and Ingredient Updates - If product ingredients or formula change, updates must be submitted to the FDA immediately. - If new ingredients are added or cosmetic ingredient requirements change, re-submission may be required.
3. Adverse Event and Consumer Claim Reporting - Adverse events that occur during product use, such as skin irritation or allergic reactions, must be reported to the FDA in accordance with MoCRA requirements. - Claims submitted by consumers should be analyzed, and if necessary, action plans should be submitted according to FDA requirements.
4. Product Safety and Quality Management - Regular safety testing, such as microbiological testing, heavy metal analysis, and preservative efficacy testing, should be conducted to maintain product quality. - Companies should periodically check and improve whether the manufacturing process complies with FDA quality management standards, or GMP.
5. Labeling and Advertising Claim Review - Companies should regularly check whether product labels comply with the latest FDA requirements. - Cosmetics advertising and marketing materials should be reviewed to ensure that they do not include drug-like efficacy claims prohibited by the FDA.
6. Response to Regulatory Changes and Legal Requirements - Since the FDA may continue to update MoCRA requirements, companies should monitor changes regularly. - If new requirements arise from amendments to MoCRA, companies should reflect them promptly.
7. Use of CDRI Solutions - CDRI provides AI-based cosmetics certification and overseas export regulatory approval solutions to help companies maintain ongoing regulatory compliance and product safety even after completing MoCRA procedures. - By reflecting the latest FDA requirements, providing automated document review, and linking adverse event reporting systems, CDRI enables more efficient management of compliance maintenance.
MoCRA strengthens the U.S. cosmetics regulatory framework compared with previous FDA regulations, significantly increasing the requirements that companies must comply with for U.S. cosmetics export and regulatory approval procedures.
1. Mandatory Manufacturer and Facility Registration - Previous FDA regulations: Registration of cosmetics manufacturers and facilities was voluntary through VCRP, or the Voluntary Cosmetic Registration Program. - MoCRA: All cosmetics manufacturers and exporters must register their facilities with the FDA, and annual renewal is required.
2. Mandatory Product Listing and Ingredient Information Submission - Previous FDA regulations: Product registration and ingredient information submission were not mandatory. - MoCRA: All cosmetic products must be listed with the FDA, and full ingredient lists, or INCI Lists, and key ingredient information must be submitted.
3. Strengthened Product Safety Assessment Requirements - Previous FDA regulations: Product safety assessment was recommended but not mandatory. - MoCRA: All cosmetic products must complete safety substantiation, and companies must be able to provide supporting evidence.
4. Strengthened Adverse Event Reporting and Consumer Protection Measures - Previous FDA regulations: Adverse event reporting was not mandatory. - MoCRA: Serious adverse events must be reported to the FDA, and companies must operate post-market management systems for consumer safety.
5. Introduction of Quality Management Standards, or GMP - Previous FDA regulations: GMP compliance for cosmetics manufacturers was not mandatory for U.S. cosmetics export. - MoCRA: The FDA requires cosmetics manufacturers to comply with GMP, and facilities and production processes must be operated accordingly.
6. Strengthened Labeling and Marketing Regulations - Previous FDA regulations: Warning statement requirements for certain ingredients were limited. - MoCRA: Allergens and other relevant ingredients contained in cosmetics must be clearly indicated, and advertising claims that may mislead consumers are restricted.
7. Use of CDRI Solutions - CDRI provides AI-based U.S. cosmetics export and regulatory approval solutions that reflect MoCRA regulatory changes in real time and help companies comply with FDA requirements quickly and accurately. - Through manufacturer and product listing automation, ingredient review systems, and latest regulatory updates, CDRI helps companies manage cosmetics certification procedures efficiently.